Akorn to buy Hi-Tech Pharmacal for $640M

Home › Akorn to buy Hi-Tech Pharmacal for $640M

Akorn Inc. plans to pay $640 million in cash to buy fellow generic drugmaker Hi-Tech Pharmacal Co.

10.05	How crops are being disaster-proofed
10.05	'I got married on a Thursday and saved 3,000'
10.05	Inland Packaging receives Molson Coors Packaging Supplier of the Year
10.05	Delays warning as M25 stretch closes for the weekend
10.05	AAPI-Owned Three Ships Beauty Raises $2.5 Million
10.05	Post Office boss denies covering tracks
10.05	Three BASF Women in Manufacturing Honored at the 2024 Women MAKE Awards
10.05	BASF Invests in Expansion of Additives Plant in Nanjing
More »

je.st